Ivacaftor is a pharmaceutical raw material used in the manufacturing of medications for cystic fibrosis. It is included in combination products alongside lumacaftor, tezacaftor, and elexacaftor for broader applicability in certain patient populations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ivacaftor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2,4-di-tert-Butyl-5-[(4-oxo-1,4-dihydroquinoline-3-carbonyl)amino]phenyl 4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
Ramipril
pharmaceutical raw material
Amtolmetin
pharmaceutical raw material
5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-N-[4-(trifluoromethyl)benzyl]pyridin-2-amine
pharmaceutical raw material
BMS-599626
pharmaceutical raw material
Deutivacaftor
pharmaceutical raw material
The international HS code for Ivacaftor (CAS 873054-44-5) is 2933.49.
2933.49
2933 49 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
PURKAOJPTOLRMP-UHFFFAOYSA-N
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
Sourcing Ivacaftor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.